Luthra et al., Microvasc Res 2008
:
However, pre-treatment with z-ATAD-fmk , a caspase-12 inhibitor , followed by 7kCh exposure lead to significantly increased caspase-8 activity
Kosuge et al., Neurochem Int 2008
(Nerve Degeneration) :
Pretreatment with z-ATAD-fmk , a cell-permeable caspase-12-selective inhibitor significantly attenuated the TM-induced increase of PI fluorescence in the CA1 and DG subregion but not in area CA3
Chien et al., Clin Exp Pharmacol Physiol 2008
:
In the presence of 50 micromol/L Z-ATAD-FMK ( a caspase 12 inhibitor ) and 100 micromol/L Z-LEHD-FMK ( a caspase 9 inhibitor ), the CTX III mediated activation of caspase 9 and caspase 3 was significantly reduced ... In the presence of 50 micromol/L Z-ATAD-FMK ( a caspase 12 inhibitor ) and 100 micromol/L Z-LEHD-FMK ( a caspase 9 inhibitor ), the CTX III mediated activation of caspase 9 and caspase 3 was significantly reduced